Exome Asset Management »

Abivax SA F shares owned by Exome Asset Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.2M 47k 133.26

More positions owned by Exome Asset Management

Guardant Health (GH)
Praxis Precision Medicines I Com New (PRAX)
Tg Therapeutics (TGTX)
Cogent Biosciences (COGT)
Ionis Pharmaceuticals (IONS)
Eli Lilly & Co. (LLY)
Abivax Sa Sponsored Ads (ABVX)
Alumis (ALMS)
Cytokinetics Com New (CYTK)
Enliven Therapeutics (ELVN)
Vera Therapeutics Cl A (VERA)
UnitedHealth (UNH)
10x Genomics Cl A Com (TXG)
Natera (NTRA)
Uniqure Nv SHS (QURE)

View all positions for Exome Asset Management

Top funds holding Abivax SA F

TCG Crossover Management
Susquehanna International
Citadel Advisors
Darwin Global Management
Helikon Investments
Vestal Point Capital
Jupiter Topco
UBS Group
ADAR1 Capital Management
Morgan Stanley
Caligan Partners
Westfield Capital Management Company
RA Capital Management
Norges Bank Investment Management
Logos Global Management

View all funds holding Abivax SA F